# Effect of Finerenone in IgA Nephropathy

> **NCT06580288** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Zhejiang University** · enrollment: 120 (estimated)

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** Finerenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06580288
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-08
- **Primary completion:** 2026-06-08
- **Final completion:** 2026-10-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06580288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06580288, "Effect of Finerenone in IgA Nephropathy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06580288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*